COMMUNIQUÉS West-GlobeNewswire

Spring Bank Pharmaceuticals Provides Corporate Update and Reports First Quarter Financial and Operational Results
27/04/2018
Presented inarigivir 25 mg and 50mg cohorts from Phase 2 ACHIEVE trial in chronic hepatitis B patients at two scientific conferences Continues to advance SB 11285, a next-generation STING agonist, towards clinical trial [...]
Acasti Pharma Appoints Donald Olds to its Board of Directors and Audit Committee
27/04/2018
LAVAL, Québec, April 27, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST ) (TSX-V: ACST ), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug [...]
Zogenix Announces Initial Quality of Life and Cognitive Function Data From Phase 3 Trial of ZX008 in Dravet Syndrome
27/04/2018
ZX008 Patients Experienced Significant Improvements on Select Measures of Quality of Life and Executive Function Compared to Those on Placebo Data Presented During Emerging Therapies Plenary Session at 2018 American [...]
Emblem Announces 2017 Financial Results
27/04/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, April 27, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. ( “Emblem” or the “ Company ”) (TSX-V: EMC ) (EMC.WT), today [...]
INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment of Prader-Willi Syndrome
27/04/2018
Study will evaluate safety and efficacy of company’s CBD product candidate in rare genetic disease characterized by insatiable appetite in children PHOENIX, April 27, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. ( [...]
Trevena and Pharmbio Korea Announce License and Commercialization Agreement for Oliceridine in South Korea
27/04/2018
– Pharmbio Korea granted a license to develop, manufacture, and commercialize oliceridine in South Korea – – Trevena to receive upfront and milestone payments and royalties – CHESTERBROOK, Pa. and SEOUL, South Korea, [...]
Establishment Labs Announces Motiva® Implants IDE Clinical Trial Underway with First Patient Enrolled and Surgery Completed
27/04/2018
NEW YORK, April 27, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies, today announced the enrollment and successful [...]
Nuvus (NUVG) Signs Letter of Intent With Kunjani Group - Nuvus Brings Its Bio-Agriculture & Blockchain Technology Solutions to Africa
27/04/2018
Kunjani Group Will Hold the Exclusive License for Nuvus Technologies in Sub-Sahara Africa Saint Petersburg, FL, April 27, 2018 (GLOBE NEWSWIRE) -- JOHANNESBURG, SOUTH AFRICA — Nuvus Corp., a pioneer in bio-agricultural [...]
Myriad Genetics to Present at Two Upcoming Healthcare Conferences
27/04/2018
SALT LAKE CITY, April 27, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]
New Study Finds that 24 Percent of Women Seen in the Obstetrics-Gynecology Setting Met NCCN Guidelines for Hereditary Cancer Genetic Testing
27/04/2018
Results from 3,800 Patient Study Will Be Presented at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting SALT LAKE CITY, April 27, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ [...]
Asterias Biotherapeutics to Present AST-OPC1 Program Update at the Upcoming American Society for Neural Therapy and Repair Conference
27/04/2018
FREMONT, Calif., April 27, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with [...]
miRagen Therapeutics Announces New Data Showing Administration of MRG-110 Improved Tissue Perfusion and Wound Healing in Late Stage Preclinical Studies
27/04/2018
MRG-110 appeared to increase vascularization and reparative tissue formation in treated wounds; miRagen believes results support evaluation in human clinical trials MRG-110 treatment appeared to lead to more wounds [...]
Agios Announces Revised Starting Time of 8:00am ET for Investor Day and First Quarter 2018 Financial Results Webcast on Friday, May 4, 2018
27/04/2018
CAMBRIDGE, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]
Advantagene Announces Clinical Trial Collaboration
27/04/2018
Clinical Study to Combine GMCI™ with Opdivo® (nivolumab) in the Treatment of Malignant Glioma AUBURNDALE, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Advantagene, Inc. today announced that the company entered into a [...]
AnaptysBio To Participate in Upcoming Investor Conferences
27/04/2018
SAN DIEGO, April 27, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]
Onconova Therapeutics Announces Pricing of $25.0 Million Upsized Underwritten Public Offering
27/04/2018
NEWTOWN, Pa., April 27, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug [...]
Aino Health AB (publ): Aino Health AB signs cooperation agreement with Finla Occupational Health
27/04/2018
Aino Health and Finla Occupational Health have signed a cooperation agreement regarding Aino's HealthManager platform. Cooperation with Finla will further expand Aino's partner network and enable scalability and growth [...]
FIT Biotech Oy: APPOINTMENT OF TOMMI HOLOPAINEN AS CFO AND AS A MEMBER OF THE MANAGEMENT TEAM OF FIT BIOTECH
27/04/2018
FIT Biotech Oy Company release 27.4.2018 at 11:00 AM EET APPOINTMENT OF TOMMI HOLOPAINEN AS CFO AND AS A MEMBER OF THE MANAGEMENT TEAM OF FIT BIOTECH Tommi Holopainen, MSc Economics, EMBA, has been appointed as a new [...]
Decision on launch of conditional, voluntary offer
27/04/2018
Company announcement 27 April 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]

Pages